Thomas Flaten
Stock Analyst at Lake Street
(4.45)
# 1,131
Out of 4,639 analysts
342
Total ratings
51.4%
Success rate
10.2%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMDX Insight Molecular Diagnostics | Maintained: Buy | $12 | $4.28 | +180.37% | 25 | Aug 11, 2026 | |
| AQST Aquestive Therapeutics | Maintained: Buy | $6 | $4.24 | +41.51% | 37 | Aug 10, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | $7 | $1.66 | +321.69% | 9 | Aug 10, 2026 | |
| BLFS BioLife Solutions | Maintained: Hold | $31 | $34.59 | -10.38% | 27 | Aug 7, 2026 | |
| PSNL Personalis | Maintained: Hold | $16 | $14.01 | +15.99% | 30 | Aug 5, 2026 | |
| CSTL Castle Biosciences | Maintained: Buy | $52 → $57 | $32.06 | +77.79% | 25 | Jul 31, 2026 | |
| AEON AEON Biopharma | Initiated Coverage: Buy | $1 | $0.275 | +263.64% | 1 | Jul 30, 2026 | |
| CNTB Connect Biopharma Holdings | Maintained: Buy | $9 | $2.29 | +293.01% | 3 | Jul 15, 2026 | |
| HROW Harrow | Maintained: Buy | $60 | $40.20 | +49.25% | 19 | Jul 1, 2026 | |
| DMAC DiaMedica Therapeutics | Reiterated: Buy | $14 | $6.97 | +101.01% | 23 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $2.38 | +194.12% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $5 | $0.4699 | +964.06% | 14 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $6.35 | +104.72% | 15 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $14.19 | +69.13% | 1 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $3.08 | +192.21% | 24 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $24.62 | +62.47% | 14 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $6.56 | +67.68% | 30 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $28.02 | +78.44% | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.60 | n/a | 15 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.5 | $0.0001 | n/a | 8 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $96 → $15 | $0.379 | n/a | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $1.97 | n/a | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $50 | $45.78 | n/a | 4 | Mar 1, 2022 |
Insight Molecular Diagnostics
Aug 11, 2026
Maintained: Buy
Price Target: $12
Current: $4.28
Upside: +180.37%
Aquestive Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $6
Current: $4.24
Upside: +41.51%
Rapid Micro Biosystems
Aug 10, 2026
Maintained: Buy
Price Target: $7
Current: $1.66
Upside: +321.69%
BioLife Solutions
Aug 7, 2026
Maintained: Hold
Price Target: $31
Current: $34.59
Upside: -10.38%
Personalis
Aug 5, 2026
Maintained: Hold
Price Target: $16
Current: $14.01
Upside: +15.99%
Castle Biosciences
Jul 31, 2026
Maintained: Buy
Price Target: $52 → $57
Current: $32.06
Upside: +77.79%
AEON Biopharma
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $1
Current: $0.275
Upside: +263.64%
Connect Biopharma Holdings
Jul 15, 2026
Maintained: Buy
Price Target: $9
Current: $2.29
Upside: +293.01%
Harrow
Jul 1, 2026
Maintained: Buy
Price Target: $60
Current: $40.20
Upside: +49.25%
DiaMedica Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $14
Current: $6.97
Upside: +101.01%
May 14, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $2.38
Upside: +194.12%
May 14, 2026
Maintained: Buy
Price Target: $9 → $5
Current: $0.4699
Upside: +964.06%
May 14, 2026
Maintained: Buy
Price Target: $13
Current: $6.35
Upside: +104.72%
May 8, 2026
Reiterated: Buy
Price Target: $24
Current: $14.19
Upside: +69.13%
May 8, 2026
Maintained: Buy
Price Target: $9
Current: $3.08
Upside: +192.21%
May 5, 2026
Maintained: Buy
Price Target: $40
Current: $24.62
Upside: +62.47%
Apr 15, 2026
Maintained: Buy
Price Target: $11
Current: $6.56
Upside: +67.68%
Mar 25, 2026
Reiterated: Buy
Price Target: $50
Current: $28.02
Upside: +78.44%
May 15, 2025
Maintained: Hold
Price Target: n/a
Current: $9.60
Upside: n/a
Nov 29, 2023
Maintained: Buy
Price Target: $1.5
Current: $0.0001
Upside: n/a
Apr 12, 2023
Maintained: Buy
Price Target: $96 → $15
Current: $0.379
Upside: n/a
Sep 16, 2022
Maintained: Buy
Price Target: $3.5
Current: $1.97
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $60 → $50
Current: $45.78
Upside: n/a